We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Structure of Enzyme for Trehalose Synthesis May Promote Drug Development

By LabMedica International staff writers
Posted on 29 Jun 2016
Print article
Image: This ribbon diagram shows two views of the structure of the enzyme Tps2 as it removes a phosphate from a sugar molecule (yellow, orange, and red). The result of this process is trehalose, which forms a tough coating on pathogenic fungi, enabling them to make the transition from the ambient temperature of the environment to the much hotter temperature inside a human host (Photo courtesy of Yi Miao, Duke University).
Image: This ribbon diagram shows two views of the structure of the enzyme Tps2 as it removes a phosphate from a sugar molecule (yellow, orange, and red). The result of this process is trehalose, which forms a tough coating on pathogenic fungi, enabling them to make the transition from the ambient temperature of the environment to the much hotter temperature inside a human host (Photo courtesy of Yi Miao, Duke University).
A team of molecular microbiologists has established the molecular structure of an enzyme required for synthesis of trehalose, a sugar required by several different pathogenic fungi.

To survive in the human host, pathogenic fungi require the disaccharide trehalose, which is formed by a 1,1-glucoside bond between two alpha-glucose units. Trehalose acts to protect the fungi from the high temperatures they experience while trying to colonize the human organism. The enzymes that synthesize trehalose are not found in humans, and thus serve as potential targets for novel antifungal drugs.

Investigators at Duke University (Durham, NC, USA) used x-ray crystallography to establish multiple structures for one of the trehalose biosynthetic enzymes, trehalose-6-phosphate phosphatase (Tps2), from Candida albicans.

In a paper published in the June 15, 2016, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences the investigators said that these structures and germane in vivo and biochemical studies revealed the significance of the Tps2 N-terminal domain in fungal cellular stress responses and the conformational flexibility of the Tps2 C-terminal domain that imposed exquisite substrate specificity and permitted efficient catalysis.

"We found that the active site of this enzyme is identical in each of these pathogenic fungi, so they all use the same mechanism and have the same residues that are necessary for the production of trehalose," said senior author Dr. Richard G. Brennan, professor of biochemistry at Duke University. "By targeting those active sites, we hope to create a drug with broad-spectrum effect. If you could kill one fungus, you are going to kill them all; at least if you can get the drug inside."

Related Links:
Duke University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.